KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Income from Continuing Operations (2016 - 2025)

Gilead Sciences (GILD) has disclosed Income from Continuing Operations for 17 consecutive years, with 2528000000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations rose 41.86% year-over-year to 2528000000.0, compared with a TTM value of 8855000000.0 through Dec 2025, up 1748.64%, and an annual FY2025 reading of 8510000000.0, up 1676.62% over the prior year.
  • Income from Continuing Operations was 2528000000.0 for Q4 2025 at Gilead Sciences, down from 3051000000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 3051000000.0 in Q3 2025 and bottomed at 4171000000.0 in Q1 2024.
  • Average Income from Continuing Operations over 5 years is 1285600000.0, with a median of 1566000000.0 recorded in 2021.
  • The sharpest move saw Income from Continuing Operations surged 8100.0% in 2023, then plummeted 523.88% in 2024.
  • Year by year, Income from Continuing Operations stood at 376000000.0 in 2021, then surged by 334.31% to 1633000000.0 in 2022, then fell by 13.29% to 1416000000.0 in 2023, then grew by 25.85% to 1782000000.0 in 2024, then surged by 41.86% to 2528000000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for GILD at 2528000000.0 in Q4 2025, 3051000000.0 in Q3 2025, and 1961000000.0 in Q2 2025.